ESC 365 - HCM: who should get an implantable cardioverter defibrillator in Europe and the US in 2022?

EHRA Premium Access

HCM: who should get an implantable cardioverter defibrillator in Europe and the US in 2022?

Session: Risk calculators in arrhythmias: are they useful?

Topic: Genetic Aspects of Arrhythmias

Speaker: Professor P. Elliott (London, GB)

Event: EHRA 2022

Congress Presentation

Add to my library

About the speaker

Professor Perry Mark Elliott

University College London, London (United Kingdom of Great Britain & Northern Ireland)

67 presentations

26 followers

4 more presentations in this session

Genetic risk calculators.

Speaker: Doctor R. Tadros (Montreal, CA)

LQTS: how to use the novel calculator.

Speaker: Doctor H. Tan (Amsterdam, NL)

ARVC in 2021: do we implant the right patients?

Speaker: Professor P. Lambiase (London, GB)

Risk calculators in arrhythmias: are they useful? - discussion.

Access the full session

Risk calculators in arrhythmias: are they useful?

Speakers: Professor P. Elliott, Doctor R. Tadros, Doctor H. Tan, Professor P. Lambiase

About the event

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources